US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth with a Strong 32% Revenue Increase

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has been capturing investor attention with its..

Abbott Laboratories (ABT) Stock Analysis: Unveiling a 31% Potential Upside for Savvy Investors

Abbott Laboratories (NYSE: ABT), a venerable name in the healthcare sector, continues to be a compelling prospect for investors seeking both stability and growth. With its..

Bristol-Myers Squibb (BMY) Investor Outlook: A Look at Its 4.30% Dividend Yield and Growth Potential

For investors with an eye on the healthcare sector, Bristol-Myers Squibb Company (NYSE: BMY) presents a compelling case with its robust dividend yield and potential for..

Edwards Lifesciences Corporation (EW) Stock Analysis: Unveiling a 24% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a leader in the medical devices industry, stands out in the healthcare sector with its innovative cardiovascular solutions. Headquartered in Irvine,..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A Biotech Powerhouse with 15.19% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers investors an intriguing opportunity for growth. With a market capitalization of $11.96 billion,..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a Potential 32.58% Upside for Investors

Bio-Techne Corp (NASDAQ: TECH) stands as a key player in the biotechnology sector, developing and manufacturing life science reagents, instruments, and services for global markets. With..

Repligen Corporation (RGEN) Stock Analysis: Uncovering a 53% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing the attention of investors with..

Insulet Corporation (PODD) Stock Analysis: Strong Growth Potential with a 72.78% Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, specializes in the development and sale of innovative insulin delivery systems. With a current market..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Potential 31.89% Upside Amid Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a titan in the healthcare sector specializing in diagnostics and research, commands a significant presence in the veterinary diagnostics market. With..

BioNTech SE (BNTX) Stock Analysis: Navigating a Complex Valuation with Promising Upside

BioNTech SE (NASDAQ: BNTX), a pioneer in the biotechnology space, has garnered significant attention for its role in developing mRNA-based therapies. With a market capitalization of..

IQVIA Holdings, Inc. (IQV) Investor Outlook: Analyzing a 38.79% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, continues to capture investor attention with its extensive portfolio of clinical research services and..

Regeneron Pharmaceuticals (REGN) Investor Outlook: Analyzing the 16.90% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology sector, has consistently positioned itself as a leader in the healthcare industry with its innovative..

argenx SE (ARGX) Investor Outlook: Navigating a Promising 28.89% Upside in Biotech

argenx SE (ARGX), a leading name in the biotechnology sector, is captivating investor attention with its robust market presence and promising growth prospects. Headquartered in the..

Elevance Health, Inc. (ELV) Stock Analysis: A 22% Upside Potential Amidst Solid Revenue Growth

Elevance Health, Inc. (NYSE: ELV), a stalwart in the healthcare sector, is currently drawing attention from the investment community. With a market capitalization of $68.76 billion,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a Promising 82.86% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a key player in the medical instruments and supplies industry, is turning heads among investors with a compelling 82.86% potential upside...

AptarGroup, Inc. (ATR) Stock Analysis: Unlocking a 23.74% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a leader in the medical instruments and supplies industry, presents an enticing opportunity for investors looking for stable growth and reliable dividends..

Bio-Rad Laboratories, Inc. (BIO) Stock Report: Navigating Healthcare Innovation with an 8.33% Upside Potential

Investors with a keen eye on the healthcare sector may find Bio-Rad Laboratories, Inc. (NYSE: BIO) an intriguing prospect. With a market capitalization of $7.54 billion,..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

AstraZeneca PLC (AZN) Stock Analysis: Navigating Growth and a Strategic Edge in Healthcare

AstraZeneca PLC (NASDAQ: AZN), a leading entity in the healthcare sector, is making waves with its robust market position and strategic advancements in the biopharmaceutical industry...

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and 23.89% Upside Potential

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), an established giant in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds